Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+42.4%
5Y CAGR+62.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+42.4%/yr
vs +251.3%/yr prior
5Y CAGR
+62.5%/yr
Recent deceleration
Acceleration
-208.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.3x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $257.03M | +27.1% |
| 2024 | $202.22M | +38.6% |
| 2023 | $145.88M | +63.8% |
| 2022 | $89.07M | +50.4% |
| 2021 | $59.22M | +161.0% |
| 2020 | $22.69M | +93.1% |
| 2019 | $11.75M | +1908.9% |
| 2018 | $585000.00 | - |